newsfilter
← Latest News
PR Newswire·

Compugen to Release Second Quarter 2025 Results on Wednesday, August 6, 2025

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...